This is the thirteenth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined....
This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...
This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
More than 200 therapeutic options or their combinations are being investigated in more than 1,700
clinical trials. In this review we examined 30 therapeutic options. Findings from the RECOVERY Trial showed that low doses of dexamethasone (6 mg of oral or intravenous preparation once daily for 10 days) si...
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Immunoglobulins/therapeutic use,
Antibodies, Monoclonal/therapeutic use,
Interferons/therapeutic use,
Mesenchymal Stem Cells,
Antiviral Agents/therapeutic use,
Glucocorticoids/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Azithromycin/therapeutic use,
Hydroxychloroquine/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Oseltamivir/therapeutic use,
Interferon alpha-2/therapeutic use,
Immunosuppressive Agents/therapeutic use,
Methylprednisolone/therapeutic use,
Methotrexate/therapeutic use,
Colchicine/therapeutic use,
Cohort Studies,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Leflunomide/therapeutic use,
Interleukin 1 Receptor Antagonist Protein/therapeutic use,
Neuromuscular Blocking Agents/therapeutic use,
Immunoglobulins/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Antiviral Agents/therapeutic use,
Antifungal Agents/therapeutic use,
Interleukins/antagonists & inhibitors,
Hydroxychloroquine/therapeutic use,
Immunosuppressive Agents/therapeutic use,
Cohort Studies,
Cross-Sectional Studies,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Immunoglobulins/therapeutic use,
Antirheumatic Agents/therapeutic use,
Prednisone/therapeutic use,
Hydroxychloroquine/therapeutic use,
Enoxaparin/therapeutic use,
Fondaparinux/therapeutic use,
Anticoagulants/therapeutic use,
Azithromycin/therapeutic use,
Antiviral Agents/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Ivermectin/therapeutic use,
Cohort Studies,
Technology Assessment, Biomedical
